Align Technologies
Price: 170.50Company and Business Model
Align Technologies is a healthcare company specializing in digital orthodontics and dental solutions. Its core products include the Invisalign clear aligner system and iTero intraoral scanners. The company primarily generates revenue through the sale of these products and associated services, targeting both dental professionals and consumers. Align operates in the orthodontics and restorative dentistry segments, focusing on innovation and technology to enhance patient outcomes.
Investment Profile
Align Technologies presents a neutral investment profile, appealing to investors seeking growth due to its innovative product offerings and market position. However, the company's recent revenue decline and elevated risk factors suggest caution. This stock may be suitable for balanced investors looking for a mix of growth potential and stability.
Fundamental metrics (experimental)
- EPS (TTM) — earnings per share for the last 12 months, $
- 5.97 OK
- Revenue QoQ — quarter-over-quarter revenue growth
- -0.7% ≈
- EPS surprise
- 14.2% better than expected
- 20d volatility
- 2.6% stable
Track in portfolio
Price chart
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-05-08 15:10 | — | Hold | Weak momentum and fundamentals raise significant risk concerns. |
| 2026-05-08 05:36 | Hold | Hold | Компания показывает смешанные результаты, с недавним снижением цен, но с положительной динамикой за 120 дней. Рекомендуется держать акции до получения более ясных сигналов о восстановлении. |
| 2026-05-01 02:57 | Buy | Hold | Компания показывает положительную динамику на длительном горизонте, однако недавние колебания цен и снижение выручки в квартальном выражении вызывают опасения. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-04-24 11:41 | Morgan Stanley | Target Raised | 169 → 188 | 190.67 |
| 2026-04-21 11:01 | Piper Sandler | Target Raised | 220 → 235 | 191.66 |
| 2026-02-25 18:30 | Barclays | Target Raised | 170 → 200 | 187.68 |